Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation

No abstract is available for this paper.

• Publication year

  2014

• Venue

  British Journal of Haematology

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bjh.12820PMID 24628463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: A single center experience on 228 patients

  2012cited by this paper
• Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents

  2010cited by this paper
• Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma

  2009cited by this paper
• Cytogenetic Guidelines and Quality Assurance: a common European framework for quality assessment for constitutional and acquired cytogenetic investigations

  2007cited by this paper
• Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma.

  2005influential reference
• High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe.

  2005cited by this paper
• International staging system for multiple myeloma.

  2005cited by this paper
• High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.

  2005cited by this paper
• Neovascularization of bone marrow in patients with diffuse multiple myeloma

  2004cited by this paper
• High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

  2003cited by this paper
• Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

  2003cited by this paper
• Imaging of myeloma bone disease--implications for staging, prognosis and follow-up.

  2000cited by this paper
• Total therapy with tandem transplants for newly diagnosed multiple myeloma.

  1999cited by this paper
• Magnetic resonance imaging of the bone marrow in hematologic malignancies.

  1997cited by this paper
• A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

  1996cited by this paper
• A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

  1996cited by this paper
• Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease.

  1992cited by this paper
• The prognostic significance of X‐ray changes at presentation and reassessment in patients with multiple myeloma

  1988cited by this paper
• High-dose chemotherapy.

  1987cited by this paper
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

  1975cited by this paper

• Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions

  2025cites this paper
• Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting

  2023cites this paper
• Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients

  2022cites this paper
• Optimization of whole-body 2-[18F]FDG-PET/MRI imaging protocol for the initial staging of patients with myeloma

  2021cites this paper
• Differentiation of Diffuse Infiltration Pattern in Multiple Myeloma From Hyperplastic Hematopoietic Bone Marrow: Qualitative and Quantitative Analysis Using Whole‐Body MRI

  2021cites this paper
• Whole-Body Low-Dose CT in Multiple Myeloma: Diagnostic Value of Appendicular Medullary Patterns of Attenuation.

  2021cites this paper
• Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value

  2021cites this paper
• Evaluation of Diffuse Bone Marrow Infiltration Pattern in Monoclonal Plasma Cell Diseases by Quantitative Whole-body Magnetic Resonance Imaging.

  2021cites this paper
• Analyzing Longitudinal wb-MRI Data and Clinical Course in a Cohort of Former Smoldering Multiple Myeloma Patients: Connections between MRI Findings and Clinical Progression Patterns

  2021cites this paper
• Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers.

  2021cites this paper
• Longitudinal monitoring of apparent diffusion coefficient (ADC) in myeloma patients with lower M-gradient levels undergoing systemic treatment and whole-body MRI monitoring.

  2020cites this paper
• Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI

  2020cites this paper
• Extended Texture Analysis of Non-Enhanced Whole-Body MRI Image Data for Response Assessment in Multiple Myeloma Patients Undergoing Systemic Therapy

  2020cites this paper
• Mid-term response assessment in multiple myeloma using a texture analysis approach on dual energy-CT-derived bone marrow images - A proof of principle study.

  2020cites this paper
• Role of computed tomography texture analysis using dual-energy-based bone marrow imaging for multiple myeloma characterization: comparison with histology and established serologic parameters

  2020cites this paper
• Imaging in multiple myeloma: Current concepts and future challenges

  2019cites this paper
• Molecular Imaging in Multiple Myeloma

  2019cites this paper
• Role of Standard Magnetic Resonance Imaging

  2019cites this paper
• Applications of PET‐MRI in musculoskeletal disease

  2018cites this paper
• Diffusion weighted Image MRI in Assessment of Patients with Multiple Myeloma

  2018cites this paper
• Practical Considerations for Bone Health in Multiple Myeloma

  2018cites this paper
• Dual-energy CT of the bone marrow in multiple myeloma: diagnostic accuracy for quantitative differentiation of infiltration patterns

  2018cites this paper
• Functional and molecular MRI of the bone marrow in multiple myeloma.

  2018cites this paper
• Guidelines for the use of imaging in the management of patients with myeloma

  2017cites this paper
• Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis

  2017cites this paper
• Quantitative Diffusion-weighted Imaging of the Bone Marrow: An Adjunct Tool for the Diagnosis of a Diffuse MR Imaging Pattern in Patients with Multiple Myeloma.

  2017cites this paper
• The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.

  2016cites this paper
• Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study

  2016cites this paper
• Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration.

  2016cites this paper
• Risk Stratification Model in Elderly Patients with Multiple Myeloma: Clinical Role of Magnetic Resonance Imaging Combined with International Staging System and Cytogenetic Abnormalities

  2015cites this paper
• Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.

  2015cites this paper
• Imaging myeloma and related monoclonal plasma cell disorders using MRI, low-dose whole-body CT and FDG PET/CT

  2015influential citation
• Vertebral lesion distribution in multiple myeloma—assessed by reduced-dose whole-body MDCT

  2015cites this paper